CD109 Antikörper (N-Term)
Kurzübersicht für CD109 Antikörper (N-Term) (ABIN951153)
Target
Alle CD109 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 77-109, N-Term
-
Spezifität
- This antibody reacts to CD109.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human and Mouse.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 77-109 amino acids from the N-terminal region of human CD109
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CD109
-
Andere Bezeichnung
- CD109 / CPAMD7
-
Hintergrund
- CD109 is a member of the alpha2-macroglobulin/complement superfamily. The encoded GPI-linked glycoprotein is found on the cell surface of platelets, activated T-cells, and endothelial cells. The protein binds to and negatively regulates signaling of transforming growth factor beta (TGF-beta).Synonyms: 150 KDa TGF-beta-1-binding protein, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7, Platelet-specific Gov antigen, p180, r150
-
Molekulargewicht
- 161689 Da
-
Gen-ID
- 135228
-
NCBI Accession
- NP_001153059
-
Pathways
- Activated T Cell Proliferation
Target
-